Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis

被引:5
|
作者
Sardo, Salvatore [1 ]
Tripodi, Vincenzo Francesco [2 ]
Guerzoni, Filippo [1 ]
Musu, Mario [1 ]
Cortegiani, Andrea [3 ,4 ]
Finco, Gabriele [1 ]
机构
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Monserrato, Italy
[2] Univ Hosp Messina, Dept Human Pathol, Unit Anesthesia & Intens Care, Messina, Italy
[3] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy
[4] Univ Hosp Policlin Paolo Giaccone, Dept Anesthesia Intens Care & Emergency, Palermo, Italy
关键词
cardiac; pulmonary hypertension; meta-analysis; vasodilator; cardiopulmonary bypass; network meta-analysis; RIGHT-VENTRICULAR FAILURE; INHALED NITRIC-OXIDE; CARDIOPULMONARY BYPASS; ARTERY HYPERTENSION; THORACIC SURGEONS; SURGICAL-PATIENTS; ORAL SILDENAFIL; VALVE SURGERY; MILRINONE; LEVOSIMENDAN;
D O I
10.1053/j.jvca.2023.07.041
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The authors performed a systematic review to evaluate the effect of pharmacologic therapy on pulmonary hypertension in the periop-erative setting of elective cardiac surgery (PROSPERO CRD42023321041). Design: Systematic review of randomized controlled trials with a Bayesian network meta-analysis. Setting: The authors searched biomedical databases for randomized controlled trials on the perioperative use of inodilators and pulmonary vasodilators in adult cardiac surgery, with in-hospital mortality as the primary outcome and duration of ventilation, length of stay in the intensive care unit, stage 3 acute kidney injury, cardiogenic shock requiring mechanical support, and change in mean pulmonary artery pressure as secondary outcomes. Participants: Twenty-eight studies randomizing 1,879 patients were included. Interventions: Catecholamines and noncatecholamine inodilators, arterial pulmonary vasodilators, vasodilators, or their combination were considered eligible interventions compared with placebo or standard care. Measurements and Main Results: Ten studies reported in-hospital mortality and assigned 855 patients to 12 interventions. Only inhaled prostacyclin use was supported by a statistically discernible improvement in mortality, with a number-needed-to-treat estimate of at least 3.3, but a wide credible interval (relative risk 1.26 x 10(-17 )-0.7). Inhaled prostacyclin and nitric oxide were associated with a reduction in intensive care unit stay, and none of the included interventions reached a statistically evident difference compared to usual care or placebo in the other secondary clinical outcomes. Conclusions: Inhaled prostacyclin was the only pharmacologic intervention whose use is supported by a statistically discernible improvement in mortality in the perioperative cardiac surgery setting as treatment of pulmonary hypertension. However, available evidence has significant limitations, mainly the low number of events and imprecision. (c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:2261 / 2271
页数:11
相关论文
共 50 条
  • [1] Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis
    Yasuhara, Jun
    Watanabe, Kae
    Watanabe, Atsuyuki
    Shirasu, Takuro
    Matsuzaki, Yuichi
    Watanabe, Hirofumi
    Takagi, Hisato
    Sumitomo, Naokata
    Kuno, Toshiki
    CARDIOLOGY IN THE YOUNG, 2023, 33 (11) : 2297 - 2311
  • [2] Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery
    Landoni, G.
    Greco, T.
    Biondi-Zoccai, G.
    Nigro Neto, C.
    Febres, D.
    Pintaudi, M.
    Pasin, L.
    Cabrini, L.
    Finco, G.
    Zangrillo, A.
    BRITISH JOURNAL OF ANAESTHESIA, 2013, 111 (06) : 886 - 896
  • [3] Systematic literature review and Bayesian network meta-analysis of episodic cluster headache drugs
    Pompilio, G.
    Migliore, A.
    Integlia, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (03) : 1631 - 1640
  • [4] Quality of Life After Bariatric Surgery—a Systematic Review with Bayesian Network Meta-analysis
    Piotr Małczak
    Magdalena Mizera
    Yung Lee
    Magdalena Pisarska-Adamczyk
    Michał Wysocki
    Małgorzata M. Bała
    Jan Witowski
    Mateusz Rubinkiewicz
    Alicja Dudek
    Tomasz Stefura
    Grzegorz Torbicz
    Piotr Tylec
    Natalia Gajewska
    Tanawat Vongsurbchart
    Michael Su
    Piotr Major
    Michał Pędziwiatr
    Obesity Surgery, 2021, 31 : 5213 - 5223
  • [5] Steroids in cardiac surgery: a systematic review and meta-analysis
    Dvirnik, N.
    Belley-Cote, E. P.
    Hanif, H.
    Devereaux, P. J.
    Lamy, A.
    Dieleman, J. M.
    Vincent, J.
    Whitlock, R. P.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (04) : 657 - 667
  • [6] Microplegia in cardiac surgery: Systematic review and meta-analysis
    Owen, Claire M.
    Asopa, Sanjay
    Smart, Neil A.
    King, Nicola
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (10) : 2737 - 2746
  • [7] Systematic review and meta-analysis in cardiac surgery: a primer
    Yanagawa, Bobby
    Tam, Derrick Y.
    Mazine, Amine
    Tricco, Andrea C.
    CURRENT OPINION IN CARDIOLOGY, 2018, 33 (02) : 184 - 189
  • [8] Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis
    Huang, Yi-lin
    Xu, Xiao-zhuo
    Liu, Jing
    Wang, Pin-yao
    Wang, Xue-li
    Feng, Hong-lin
    Liu, Cheng-jiang
    Han, Xu
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [9] Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis
    Yi-lin Huang
    Xiao-zhuo Xu
    Jing Liu
    Pin-yao Wang
    Xue-li Wang
    Hong-lin Feng
    Cheng-jiang Liu
    Xu Han
    BMC Cardiovascular Disorders, 23
  • [10] SURGERY FOR OBESITY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Alobaid, H.
    Wells, G.
    OBESITY SURGERY, 2014, 24 (08) : 1140 - 1140